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INTRODUCTION
Carotid body tumors (CBTs) are slow-growing hypervascular
tumors arising from paraganglionic cells of the carotid body which
acts as a vascular chemoreceptor organ and is usually located in
the posteromedial wall of the CCA at the carotid bifurcation. CBTs
are most commonly found among paragangliomas that are typi-
cally located in four main sites in the head and neck: the carotid
bifurcation (CBT), the foramen jugulare (jugular paraganglioma),
the middle ear cavity (tympanic paraganglioma), and along the
cervical portion of the vagus nerve (vagal paraganglioma) (1). 
Surgery is the gold standard for curative treatment of CBTs.
The first successful CBT excision was performed by Albert in
1889 (2), and Gordon-Taylor (3) described a safe, subadventi-
tial dissection in 1940. Since the 1980s, devascularization of
Objectives. The objective of this study was to review our experience in the surgical management of carotid body para-
gangliomas and evaluate the outcomes and complications according to the Shamblin classification.
Methods. Thirteen patients who had been diagnosed and surgically treated for carotid body tumors (CBTs) were enrolled
in this study. We reviewed patient demographics, radiographic findings, and surgical outcomes collected from med-
ical records.
Results. Fifteen CBTs were found in 13 patients and 13 tumors were resected. Selective preoperative tumor embolization
was performed on six patients. The median blood loss, operation time, and hospital stay for these patients were not
significantly reduced compared to those without embolization. The median tumor size was 2.3 cm in Shamblin I and
II and 4 cm in Shamblin III. The median intraoperative blood loss was 280 mL and 700 mL, respectively (P<0.05).
Internal carotid artery ligation with reconstruction was accomplished on three patients (23%), and they all belonged
to Shamblin III (38%). One Shamblin III patient (8%) developed transient cerebral ischemia, and postoperative
stroke with death occurred in another Shamblin III patient. Postoperative permanent cranial nerve deficit occurred in
three patients (23%) who were all in Shamblin III (P=0.03). There were no recurrences or delayed complications at
the median follow up of 29 months. 
Conclusion. Shamblin III had a high risk of postoperative neurovascular complications. Therefore, early detection and
prompt surgical resection of CBTs will decrease surgical morbidity. 
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CBTs by ligation of feeding branches of the external carotid artery
(ECA) during operation has been a common practical technique.
Recently, van der Bogt et al. (4) proposed a craniocaudal dissec-
tion technique that would minimize postoperative morbidity.
Although advances in surgical techniques and the introduction of
sensitive imaging modalities have significantly reduced mortality,
the incidence of perioperative neurovascular complications, espe-
cially cranial nerve (CN) deficit and intraoperative hemorrhage,
remains considerable (5, 6). 
Since Shamblin et al. proposed the classification of CBTs
based on the involvement of carotid vessels in 1971, it has been
widely used to describe the CBTs (7). Shamblin group I tumors
are localized and do not involve the surrounding major vessels,
group II are adherent or partially surround the vessels, and group
III are large and encase the vessels. The size of tumor is posi-
tively correlated with the Shamblin classification because CBTs
become more adherent to carotid vessels as they become larg-
er. However, clinical implications of Shamblin classification in
perioperative complications or prognosis have not well docu-
mented in the literature (8, 9). The purpose of this study was to
review our experience in the surgical management of CBTs and
evaluate the outcomes and complications according to the
Shamblin classification.
MATERIALS AND METHODS
We included 15 CBTs of 13 patients who had been diagnosed
and surgically treated at a single institute in this study. Patients
consisted of 6 men and 7 women, and their age ranged from 34
to 61 yr (median, 44 yr). The medical records of each patient were
reviewed for demographic details, radiologic findings, surgical
outcomes, and follow up. 
Imaging studies included computed tomography (CT) and/or
magnetic resonance (MR) imaging for the evaluation of tumor
size and Shamblin group. Preoperative conventional angiogra-
phy was performed in all patients and tumor embolization was
accomplished if possible. Preoperative embolization was not rou-
tinely performed when the feeding vessels of the tumor are very
close to the internal carotid artery (ICA) with a high risk of embol-
ic particle migration to ICA or if there are multiple anastomoses
between carotid vessels and tumors, thus complicating identifica-
tion of the feeding vessels. Tolerance to carotid balloon occlusion
was also tested in all patients. Surgery was performed within 48
hr of embolization to avoid recruitment of collateral blood sup-
ply and minimize inflammatory reaction in patients who were
given preoperative embolization. 
The surgical procedures are briefly described as follows: CBTs
were exposed through a transverse cervical incision. All neurovas-
cular structures were identified and periadventitial dissections of
the carotid artery were performed. Proximal and distal control
of the ICA, ECA, and common carotid artery (CCA) were per-
formed before tumor resection. Any feeding vessels supplying
the tumor were ligated early, and the ECA was selectively ligat-
ed for complete tumor resection. When a portion of the carotid
artery had to be resected, vascular surgeons performed carotid
artery reconstruction using an autologous saphenous vein or
prosthetic vascular graft (Hemashield, Woven Double Velour,
Boston Scientific Corp., Wayne, NJ, USA).
The follow up period ranged from 15 to 64 months with a medi-
an follow up of 29 months. SPSS ver. 12.0 (SPSS Inc., Chicago, IL,
USA) was used for statistical analysis. Differences between the
two groups were analyzed by Mann-Whitney test. Significance
was defined as a P-value less than 0.05. 
RESULTS
Fifteen CBTs were found in 13 patients and 13 tumors were resect-
ed. Four tumors (31%) were located in the right and seven (54%)
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Fig. 1. A 35-yr-old woman with a characteristic carotid body paraganglioma. (A) Axial contrast-enhanced CT shows an avidly enhancing mass
splaying the external carotid artery (ECA) and internal carotid artery (ICA) at the left carotid bifurcation. (B) Axial T1- weighted images show a
mass with prominent vascular flow voids. (C) Angiography shows intense tumor blush between the ICA and ECA. 
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in the left. Two patients (15%) had bilateral CBTs. A multicentric
paraganglioma not from the head and neck was discovered in one
patient (8%) who had a cardiac paraganglioma. No patient had a
family history of paraganglioma. The most common symptom was
a pulsatile neck mass without CN deficit. No patient had function-
ing CBT that presented with palpitations, tachycardia, and hyper-
tension accompanying elevated catecholamine level. Preoperative
CN X dysfunction was observed in 1 patient (8%).
CT and MR imaging revealed enhancing mass splaying the
ICA and ECA of the carotid bifurcation (Fig. 1), and the medi-
an tumor size of 13 CBTs was 3.6 cm (range, 2 to 5.5 cm). One
tumor (8%) was Shamblin class I, four (31%) were class II, and
eight (61%) were class III. The ascending pharyngeal artery
was a major feeding artery for tumors. 
Tumor embolization was performed on six patients (46%) with
polyvinyl alcohol particles after superselection of feeding arteries.
The others were unable to undergo embolization because they
had numerous feeding arteries that could reduce the effect of
embolization and the potential high risk of cerebral infarction
by embolic particles. No patient demonstrated complications
following angiography or embolization. Tumor size and Shamblin
group was not significantly different between the embolization
and non-embolization groups (P>0.05). The median intraopera-
tive blood loss was 400 mL (range, 200 to 1,200 mL) in the
embolization group and 550 mL (range, 200 to 1,400 mL) in
the non-embolization group. The median operation time was
360 minutes and hospitalization was 8 days for both groups.
These parameters of the embolization group were not signifi-
cantly reduced compared to the non-embolization group
(P>0.05) (Table 1). 
According to the Shamblin classification, the median tumor
size was 2.3 cm (range, 2 to 3.5 cm) in Shamblin I and II and 4
cm (range, 3.2 to 5.5) in Shamblin III (P=0.005). The median
intraoperative blood loss was 280 mL (range, 200 to 400 mL)
in Shamblin I and II and 700 mL (range, 500 to 1,400 mL) in
Shamblin III (P=0.003), and operation time, including ICA
reconstruction time, was 240 min (range, 180 to 360 min) and
420 min (range, 220 to 540 min), respectively (P=0.019).
Hospitalization was 8 days in both groups (Table 2). 
The ECA was ligated in five patients (39%) during operation.
After tumor resection, small tears in the ICA in two patients who
belonged to Shamblin II and III, respectively, were repaired pri-
marily. A portion of the ICA had to be resected in three patients
(23%), and they all belonged to Shamblin III (38%). Of the
three cases with ICA resection, saphenous vein interposition
was performed on two patients and prosthetic vascular graft
interposition on one patient (Table 3). 
One patient (8%) had transient cerebral ischemia immediate-
ly after operation that was likely associated with manipulation
of the ICA during vascular reconstruction. One patient (8%)
died of postoperative intracranial hemorrhage after thromboly-
sis for ICA thrombosis. These complications were all observed
in Shamblin III (25%).
Postoperative CN deficits developed in five patients (39%)
immediately after surgery, and they all belonged to Shamblin
III (63%, P=0.03). They included three CN X, one CN XII, and
one superior laryngeal nerve. Two of them who had CN X deficits
recovered within 6 months, and postoperative permanent CN
deficit occurred in three patients (23%). One patient presented
with preoperative CN X dysfunction demonstrated postopera-
tive permanent vocal fold paralysis and eventually underwent
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Group I (n=7) Group II (n=6) P-value
Table 1. Comparison of embolization (I) and nonembolization group (II)
Shamblin group 4 type II, 3 type III 1 type I, 5 type III 0.151
Tumor size (cm) 3.5 (2.2-5.5) 3.9 (2-5.5) 0.829
Estimated blood 
loss (mL)
400 (200-1200) 550 (200-1400) 0.386
Operation time (min) 360 (180-540) 360 (220-480) 0.943
Hospitalization (days) 8 (4-12) 8 (6-10) 0.828
Shamblin I and II Shamblin III
(n=5) (n=8)
P-value
Table 2. Surgical records of tumors according to Shamblin group
Tumor size (cm) 2.3 (2-3.5) 4 (3.2-5.5) 0.005
Estimated blood 
280 (200-400) 700 (500-1400) 0.003
loss (mL)
Operation time (min) 240 (180-360) 420 (220-540) 0.019
Hospital stay (days) 8 (8-11) 8 (4-12) 0.524
Shamblin I and II Shamblin III
(n=5) (n=8)
P-value
Table 3. Postoperative neurovascular complications according to
Shamblin group
Vascular repair 0.299
Primary closure 1 (8) 1 (8)
Saphenous vein graft - 2 (15)
Prosthetic vascular graft - 1 (8)
Stroke 0.243
Transient - 1 (8)
Permanent - 1 (8)*
Postoperative CN deficit 0.03
IX - -
X - 3 (23)
XI - -
XII - 1 (8)
Sympathetic nerve - -
Superior laryngeal nerve - 1
Values are presented as number (%).
CN: cranial nerve.
*Postoperative intracranial hemorrhage after thrombolysis of internal
carotid artery thrombosis caused by postoperative hematoma compres-
sion. Vagus nerve paralysis; two patients had transient vocal fold paraly-
sis and one patient had permanent vocal fold paralysis.
medialization laryngoplasty. 
Pathologic examination of all tumors revealed benign histol-
ogy of paragangliomas without cases of malignant CBT. There
was no recurrence or delayed complications at the median fol-
low up of 29 months.
DISCUSSION
Although most CBTs are benign and slow growing, surgical exci-
sion is the treatment of choice. Some authors have found that
radiotherapy is effective in inhibiting further growth of CBTs.
However, it is often considered to be an alternative treatment
modality for patients who cannot undergo surgery due to exten-
sive involvement, multiple tumors, and high operative risk (10).
During operation, all neurovascular structures should be iden-
tified to reduce complications. Proximal and distal control of the
carotid arteries with early ligation of feeding arteries is important
to achieve complete tumor resection. Elective ECA ligation can
be helpful for tumor mobilization, but the hemostatic effect of
proximal ECA ligation is still controversial (1, 11).   
When a portion of the ICA must be resected, immediate vas-
cular control and reconstruction are essential. On small tears,
primary closure or patch angioplasty can be performed to repair
them. In cases of ICA resection, it is necessary to perform inter-
position graft or ECA transposition. The grafts used for carotid
reconstruction include autologous grafts such as saphenous vein
and femoral artery/vein, cryopreserved arterial homograft, and
prosthetic graft using polytetrafluoroethylene (PTFE) or Dacron.
During ICA clamping, carotid shunting can reduce the risk of
stroke.
Regarding vascular complications, an incidence of 2% to 13%
has been reported for injury of ICA with or without reconstruc-
tion (8, 9). The sacrifice of ECA and ICA has been performed
as 13-33% and 11%, respectively (9). In our study, ECA liga-
tion was performed on 39% of the patients, and ICA ligation
with reconstruction on 23%. It was noted that the incidence of vas-
cular complications was higher than previous literature because our
cases included more advanced staged tumor with a relatively small
number of total patients.
Cerebrovascular complication such as stroke associated with
or without manipulation of major neck vessels can occur, and
its incidence has been reported to be 0 to 11% (9, 12). Postsurgical
neurological complication such as CN deficit can occur, and the
incidence of postoperative permanent CN deficit ranges from
6.9 to 42% (4, 8, 11, 12). The hypoglossal nerve (CN XII) and
vagus nerve (CN X) appeared to be most vulnerable to injury from
the sacrifice or retraction. In our study, the overall incidence of post-
operative permanent neurovascular morbidity was 31%. Permanent
CN deficit was found in 23% of the patients, and motality caused by
stroke occurred in one patient. 
In terms of the relationship between Shamblin group and
complication, all patients who had permanent neurovascular
morbidity and carotid reconstruction were Shamblin III. These
results also support the reports that the Shamblin classification
can be used to estimate the postoperative neurovascular com-
plications (6, 11), and early detection and prompt surgical
resection of CBTs will decrease surgical morbidity. However,
the Shamblin classification has some limitations because it does
not reflect how deep tumor infiltrates through the wall of carotid
vessels, which decides if it is possible to preserve the carotid ves-
sels. Recently, Luna-Ortiz et al. (9) proposed modification of the
Shamblin classification to make Shamblin IIIb which is clinically
or histologically confirmed to infiltrate the adventitia regardless
of tumor size. 
Initial diagnostic imaging studies usually include CT or MR
imaging plus angiography. CT shows an avidly enhancing mass
at the carotid bifurcation, and MR imaging depicts a mass with
the characteristic “salt and pepper” appearance, especially in
larger ones (1). Recently, it has been reported that contrast-enhanced
MR angiography can be a noninvasive and quick diagnostic tool
replacing catheter angiography for the assessment of head and neck
paragangliomas (13). The goals of CBT angiography are to pro-
vide a vascular road map for surgeons, search for multicentric
synchronous tumors, and enable preoperative embolization for
prophylactic hemostasis. Additionally, it could evaluate collat-
eral arterial and venous circulation of the brain if an inevitable
sacrifice of major vessels were necessary (1). 
There has been controversy concerning the usefulness of pre-
operative embolization. Some authors prefer routine preopera-
tive embolization because it can lower blood flow and decrease
tumor size (14, 15). Others have found that selective preopera-
tive embolization can facilitate tumor excision with less blood
loss, particularly in larger tumors (Shamblin type II and III) (1,
4, 16, 17), while some groups disagree on preoperative routine
embolization due to postembolization morbidity such as the poten-
tial risk of stroke by embolic particles (4, 18). 
In our study, there was no significant difference in intraoper-
ative blood loss and operation time between the embolization
and non-embolization groups. These results suggest that the degree
of invasion of tumors to the wall of carotid vessels and surgeon’s
experience might be more important factors for intraoperative bleed-
ing than the effects of embolization in selected cases. However, it
was difficult to draw a conclusion on the effect of preoperative
embolization because of the retrospective nature of this study
and a relatively small number of patients who had undergone
preoperative embolization.
In conclusion, Shamblin III had a high risk of postoperative
neurovascular complications. Therefore, early detection and
prompt surgical resection of CBTs will decrease surgical mor-
bidity. In addition, a team approach involving head and neck
and vascular surgeons and interventional radiologists for the
evaluation and management of these lesions will improve treat-
ment outcomes.
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